Janarthanan Sathananthan

Apr 27, 2023 | citoday.com | David Meier |Stephane Fournier |Janarthanan Sathananthan

Transcatheter aortic valve replacement (TAVR) is now a well-established treatment option for patients with severe aortic stenosis, irrespective of surgical risk, and the 2020 American College of Cardiology/American Heart Association guidelines for management of patients with valvular heart disease suggest that TAVR is an acceptable treatment option for patients aged > 65 years.1 Additionally, recent data from the United States showed that in 2021, 47% of patients undergoing aortic valve...